Advice on public- and animal-health impact

by Editor fleischwirtschaft.com
Monday, April 22, 2013

The European Medicines Agency (EMA) will provide advice on the impact on public health and animal health of the use of antibiotics in animals. The request was made by the European Commission as part of its ‘action plan against the rising threats from antimicrobial resistance’.

The Commission has asked the Agency to assess the impact on public health and animal health of the use of antibiotics in animals and to give advice on measures to manage the possible risk to humans arising from use of antibiotics in animals.

The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) and Committee for Medicinal Products for Human Use (CHMP) will work together in providing the Agency’s advice, which is expected to provide a sound scientific basis to inform decisions on the way in which antibiotics are used in animals.

The Agency will establish a multidisciplinary working group made up of experts from both committees, from the CVMP Antimicrobials Working Party and the CHMP Infectious Diseases Working Party. The advice will have input from the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA). The group will also call on additional expertise as required to address the range of questions to be answered, underlining the multisectorial approach to tackling antimicrobial resistance.

The group will seek the views of stakeholders on relevant topics as part of the input to be considered when formulating its advice. It will be delivered in a step-wise approach, with the first outcome requested by June 2013 and finalisation expected for the end of 2014.

The Agency will provide regular updates on the progress of its work during the process.
stats